Literature DB >> 35532065

Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis.

Muhammad R A Shipa1, Lawrence Langley2, Benjamin Sacks2, Su-Ann Yeoh1, M D Mainuddin3, Dev Mukerjee3, Madhura Castelino1, Michael R Ehrenstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35532065      PMCID： PMC9434146          DOI： 10.1093/rheumatology/keac276

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.046


× No keyword cloud information.
  14 in total

Review 1.  2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

Authors:  Désirée van der Heijde; Sofia Ramiro; Robert Landewé; Xenofon Baraliakos; Filip Van den Bosch; Alexandre Sepriano; Andrea Regel; Adrian Ciurea; Hanne Dagfinrud; Maxime Dougados; Floris van Gaalen; Pál Géher; Irene van der Horst-Bruinsma; Robert D Inman; Merryn Jongkees; Uta Kiltz; Tore K Kvien; Pedro M Machado; Helena Marzo-Ortega; Anna Molto; Victoria Navarro-Compàn; Salih Ozgocmen; Fernando M Pimentel-Santos; John Reveille; Martin Rudwaleit; Jochen Sieper; Percival Sampaio-Barros; Dieter Wiek; Jürgen Braun
Journal:  Ann Rheum Dis       Date:  2017-01-13       Impact factor: 19.103

2.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

Authors:  William Taylor; Dafna Gladman; Philip Helliwell; Antonio Marchesoni; Philip Mease; Herman Mielants
Journal:  Arthritis Rheum       Date:  2006-08

3.  Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.

Authors:  Tomomi Kato; Akinobu Hamada; Shunsuke Mori; Hideyuki Saito
Journal:  Drug Metab Pharmacokinet       Date:  2011-11-22       Impact factor: 3.614

4.  Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

Authors:  A E van Ede; R F J M Laan; H J Blom; G H J Boers; C J Haagsma; C M G Thomas; T M De Boo; L B A van de Putte
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

5.  Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.

Authors:  P Angelis-Stoforidis; F J Vajda; N Christophidis
Journal:  Clin Exp Rheumatol       Date:  1999 May-Jun       Impact factor: 4.473

6.  Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.

Authors:  Thierry Dervieux; Rong Zablocki; Joel Kremer
Journal:  Rheumatology (Oxford)       Date:  2010-08-16       Impact factor: 7.580

Review 7.  Methotrexate for ankylosing spondylitis.

Authors:  Junmin Chen; Mirella M S Veras; Chao Liu; Junfang Lin
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  Prediction of response to methotrexate in rheumatoid arthritis.

Authors:  Stephanie Ling; James Bluett; Anne Barton
Journal:  Expert Rev Clin Immunol       Date:  2018-04-26       Impact factor: 4.473

9.  A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Authors:  Gabrielle H Kingsley; Anna Kowalczyk; Helen Taylor; Fowzia Ibrahim; Jonathan C Packham; Neil J McHugh; Diarmuid M Mulherin; George D Kitas; Kuntal Chakravarty; Brian D M Tom; Aidan G O'Keeffe; Peter J Maddison; David L Scott
Journal:  Rheumatology (Oxford)       Date:  2012-02-17       Impact factor: 7.580

10.  Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.

Authors:  Maurits C F J de Rotte; Saskia M F Pluijm; Pascal H P de Jong; Maja Bulatović Ćalasan; Nico M Wulffraat; Angelique E A M Weel; Jan Lindemans; J M W Hazes; Robert de Jonge
Journal:  PLoS One       Date:  2018-12-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.